All Stories

  1. Differences in VigiBase® reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment

    Article • Pharmacoepidemiology and Drug Safety, November 2016, Wiley

    Mr. Evans L Sagwa

  2. Adverse drug events and patients' HRQoL at end of TB treatment

    Article • Patient Preference and Adherence, November 2016, Dove Medical Press

    Mr. Evans L Sagwa